Abstract 419P
Background
Mammogram is a mandatory screening test for women from 40 years of age in the most parts of the world. While the structural screening for Coronary artery disease doesn’t exist but Women with breast cancer share common risk factors for coronary artery disease (CAD) as well. By using mammogram we can detect the potentially high risk patients, common for both the diseases and this is going to help in long way. Literature suggests that breast arterial classification exist in up to 8- 26% in women undergoing mammogram. In this study we have explored incidence of the total calcifications on mammogram and the percentage of people having Coronary artery diseases in a retrospective to manner.
Methods
It’s a retrospective observation of all mammograms done in past one year for routine screening from three institutes during the study period 2020-2021. Those with calcifications were interviewed and for the willing population we evaluated the coronary artery disease status clinically and radiologically. The mammogram calcifications were classified into mild, moderate, and severe as per the existing literature, so as the findings of the coronary angiogram. The incidence of the calcifications and the presence of CAD in the population were represented as percentages. Medcalc software version 10.1 was used for the analysis.
Results
There are 400 subjects whose complete case records besides the mammograms were available during the study period. Out of these patients 45 had some form of calcifications on mammograms with varying severity. Out of the 45 subjects 38 patients had coronary angiogram testing (either conventional or CT). We could observe 30 of them harboring moderate to severe atherosclerotic changes and varying degree of coronary artery stenosis.
Conclusions
Conclusion The results here hence strongly advocate the radiologists to report the same findings and should prompt the screening physician to encourage the patients for their cardiac risk assessment. In these multi-centre study patients with suspected coronary artery disease, our timely intervention changed the diagnosis and management of patients, who underwent mammogram for screening, but were unaware of the coronary disease, which led to improved outcomes on cardiac aspects.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
420P - Predictive factors of post-operative acute kidney injury after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis: A retrospective cohort study
Presenter: Chito Cabiling
Session: Poster viewing 06
421P - The association between early changes in neutrophil-lymphocyte ratio and survival in patients treated with immunotherapy
Presenter: Deniz Can Guven
Session: Poster viewing 06
422P - Molecular mechanism in prostate cancer with TP53 mutation
Presenter: Bin Hu
Session: Poster viewing 06
423P - Maintaining a national essential medicine list for cancer in Malaysia: Where do we stand?
Presenter: David Lee
Session: Poster viewing 06
424P - The Storm: Paraneoplastic leucomoid reaction - A bad prognostic factor
Presenter: Abdullah Al Mamun Khan
Session: Poster viewing 06
425P - Preliminary study: Assessment of public trust in traditional medicine and medical treatment in cancer patients in Indonesia - Study validity and reliability of the Universitas Sebelas Maret Trust and readiness assessment for cancer patients (UNS – TRAfCP35) questionnaire
Presenter: Widyanti Soewoto
Session: Poster viewing 06
426P - Safety of Sputnik V COVID-19 vaccine in cancer patients receiving chemotherapy: An observational study
Presenter: Alexey Rumyantsev
Session: Poster viewing 06
427P - Oncology combination therapies in Asia-Pacific markets: What are the current access challenges?
Presenter: Gayathri Kumar
Session: Poster viewing 06
428P - Clinical characteristics, laboratory parameters, and hospital outcomes of COVID-19 among patients with and without cancer: A retrospective cohort study
Presenter: PRASHANT SIROHIYA
Session: Poster viewing 06
429P - Cancer and COVID-19 in India: Assessing the impact in a nationwide survey
Presenter: Bharti Devnani
Session: Poster viewing 06